| Year |
Citation |
Score |
| 2023 |
McCrury M, Swafford K, Shuttleworth SL, Mehdi SH, Acharya B, Saha D, Naceanceno K, Byrum SD, Storey AJ, Xu YZ, Doshier C, Patel V, Post GR, De Loose A, Rodriguez A, ... ... Kendrick S, et al. Bifunctional inhibitor reveals NEK2 as a therapeutic target and regulator of oncogenic pathways in lymphoma. Molecular Cancer Therapeutics. PMID 37816504 DOI: 10.1158/1535-7163.MCT-23-0299 |
0.329 |
|
| 2022 |
Swafford K, Acharya B, Xu YZ, Raney T, McCrury M, Saha D, Frett B, Kendrick S. Targeting a Novel G-Quadruplex in the Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group. Genes. 13. PMID 35885931 DOI: 10.3390/genes13071144 |
0.379 |
|
| 2021 |
Brown SL, Kendrick S. The i-Motif as a Molecular Target: More Than a Complementary DNA Secondary Structure. Pharmaceuticals (Basel, Switzerland). 14. PMID 33513764 DOI: 10.3390/ph14020096 |
0.427 |
|
| 2020 |
Xu YZ, Jenjaroenpun P, Wongsurawat T, Byrum SD, Shponka V, Tannahill D, Chavez EA, Hung SS, Steidl C, Balasubramanian S, Rimsza LM, Kendrick S. Activation-induced cytidine deaminase localizes to G-quadruplex motifs at mutation hotspots in lymphoma. Nar Cancer. 2: zcaa029. PMID 33094287 DOI: 10.1093/narcan/zcaa029 |
0.317 |
|
| 2020 |
Shponka V, Reveles CY, Alam S, Jaramillo M, Maguire A, Rimsza LM, Kendrick S. Frequent expression of activation induced cytidine deaminase in diffuse large B-cell lymphoma tissues from persons living with HIV. Aids (London, England). PMID 32773475 DOI: 10.1097/Qad.0000000000002653 |
0.343 |
|
| 2019 |
Chen J, Kendrick S, Qin Z. Mechanistic Insights into Chemoresistance Mediated by Oncogenic Viruses in Lymphomas. Viruses. 11: 1161. PMID 31888174 DOI: 10.3390/V11121161 |
0.306 |
|
| 2019 |
Maguire A, Chen X, Wisner L, Malasi S, Ramsower C, Kendrick S, Barrett MT, Glinsmann-Gibson B, McGrath M, Rimsza LM. Enhanced DNA repair and genomic stability identify a novel HIV related Diffuse Large B-cell Lymphoma signature. International Journal of Cancer. PMID 31044434 DOI: 10.1002/Ijc.32381 |
0.365 |
|
| 2019 |
Maguire A, Chen X, Wisner L, Malasi S, Ramsower C, Kendrick S, Barrett MT, Glinsmann-Gibson B, McGrath M, Rimsza L. Reduced Bcl2 Expression Suggests Alternative Survival Mechanisms In Hiv(+) Diffuse Large B Cell Lymphoma (Dlbcl) Of Germinal Center Origin Hematological Oncology. 37: 198-198. DOI: 10.1002/Hon.12_2630 |
0.372 |
|
| 2018 |
Xu Y, Raney T, Kendrick SL. Discovery of DNA G-Quadruplexes As a New Target for B-Cell Receptor Signaling Inhibition in Diffuse Large B-Cell Lymphoma Blood. 132: 3502-3502. DOI: 10.1182/Blood-2018-99-116793 |
0.417 |
|
| 2017 |
Kendrick S, Muranyi A, Gokhale V, Hurley LH, Rimsza LM. Simultaneous Drug Targeting of the Promoter MYC G-Quadruplex and BCL2 i-Motif in Diffuse Large B-Cell Lymphoma Delays Tumor Growth. Journal of Medicinal Chemistry. PMID 28605593 DOI: 10.1021/Acs.Jmedchem.7B00298 |
0.655 |
|
| 2016 |
Kendrick S, Rimsza LM, Scott DW, Slack GW, Farinha P, Tan KL, Persky D, Puvvada S, Connors JM, Sehn L, Gascoyne RD, Schmelz M. Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma. Virchows Archiv : An International Journal of Pathology. PMID 27888357 DOI: 10.1007/S00428-016-2041-7 |
0.377 |
|
| 2016 |
Kendrick S, Kang HJ, Alam MP, Madathil MM, Agrawal P, Gokhale V, Yang D, Hecht SM, Hurley LH. Correction to "The Dynamic Character of the BCL2 Promoter i-Motif Provides a Mechanism for Modulation of Gene Expression by Compounds That Bind Selectively to the Alternative DNA Hairpin Structure". Journal of the American Chemical Society. PMID 27571358 DOI: 10.1021/jacs.6b07292 |
0.565 |
|
| 2016 |
Kendrick SL, Gokhale V, Hurley L, Rimsza L. Concurrent Targeting of BCL2 and MYC Transcription Leads to Chemo-Sensitization of Dual-Expressing Diffuse Large B-Cell Lymphoma In Vivo Blood. 128: 4090-4090. DOI: 10.1182/Blood.V128.22.4090.4090 |
0.539 |
|
| 2015 |
Kendrick S, Tus K, Wright G, Jaffe ES, Rosenwald A, Campo E, Chan WC, Connors JM, Braziel RM, Ott G, Delabie J, Cook JR, Weisenburger DD, Greiner TC, Fu K, et al. Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status. Leukemia & Lymphoma. 1-4. PMID 26437080 DOI: 10.3109/10428194.2015.1072767 |
0.403 |
|
| 2015 |
Li L, Pongtornpipat P, Tiutan T, Kendrick SL, Park S, Persky DO, Rimsza LM, Puvvada SD, Schatz JH. Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1. Leukemia. PMID 25882699 DOI: 10.1038/Leu.2015.99 |
0.396 |
|
| 2015 |
Kendrick SL, Tannahill D, Balasubramanian S, Rimsza LM. Concurrent BCL2 / MYC Gene Amplification Associates with Increased DNA G-Quadruplex Formation in DLBCL Blood. 126: 2641-2641. DOI: 10.1182/Blood.V126.23.2641.2641 |
0.446 |
|
| 2014 |
Kendrick SL, Redd L, Muranyi A, Henricksen LA, Stanislaw S, Smith LM, Perry AM, Fu K, Weisenburger DD, Rosenwald A, Ott G, Gascoyne RD, Jaffe ES, Campo E, Delabie J, et al. BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma. Human Pathology. 45: 2144-53. PMID 25090918 DOI: 10.1016/J.Humpath.2014.06.005 |
0.41 |
|
| 2014 |
Kang HJ, Kendrick S, Hecht SM, Hurley LH. The transcriptional complex between the BCL2 i-motif and hnRNP LL is a molecular switch for control of gene expression that can be modulated by small molecules. Journal of the American Chemical Society. 136: 4172-85. PMID 24559432 DOI: 10.1021/Ja4109352 |
0.588 |
|
| 2014 |
Kendrick S, Kang HJ, Alam MP, Madathil MM, Agrawal P, Gokhale V, Yang D, Hecht SM, Hurley LH. The dynamic character of the BCL2 promoter i-motif provides a mechanism for modulation of gene expression by compounds that bind selectively to the alternative DNA hairpin structure. Journal of the American Chemical Society. 136: 4161-71. PMID 24559410 DOI: 10.1021/Ja410934B |
0.629 |
|
| 2014 |
Li L, Pongtornpipat P, Tiutan T, Kendrick SL, Park S, Persky DO, Rimsza LM, Puvvada SD, Schatz JH. Potent Efficacy of BCL2 Inhibition with ABT-199 in High-Risk Aggressive B-Lymphoma Models When Combined with Knockdown of MCL1 Blood. 124: 506-506. DOI: 10.1182/Blood.V124.21.506.506 |
0.441 |
|
| 2014 |
Kendrick SL, Tus K, Scott DW, Wright G, Jaffe ES, Rosenwald A, Campo E, Chan WC, Connors JM, Braziel RM, Ott G, Delabie J, Cook JR, Weisenburger DD, Greiner TC, et al. Cell-of-Origin Subtype Classification of Diffuse Large B-Cell Lymphoma Using the Lymph2Cx Assay Retains Relevance in the Context of BCL2 and MYC Expression Status Blood. 124: 1667-1667. DOI: 10.1182/Blood.V124.21.1667.1667 |
0.346 |
|
| 2013 |
Puvvada SD, Kendrick S, Rimsza LM. Molecular classification, pathway addiction, and therapeutic targeting in diffuse large B cell lymphoma. Cancer Genetics and Cytogenetics. 206: 257-265. PMID 24080457 DOI: 10.1016/J.Cancergen.2013.07.003 |
0.433 |
|
| 2013 |
Valentino C, Kendrick S, Johnson N, Gascoyne R, Chan WC, Weisenburger D, Braziel R, Cook JR, Tubbs R, Campo E, Rosenwald A, Ott G, Delabie J, Jaffe E, Zhang W, et al. Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large b-cell lymphoma American Journal of Clinical Pathology. 139: 242-254. PMID 23355209 DOI: 10.1309/Ajcp2Z0Tagmuyjeb |
0.354 |
|
| 2010 |
Kendrick S, Hurley LH. The role of G-quadruplex/i-motif secondary structures as cis-acting regulatory elements. Pure and Applied Chemistry. Chimie Pure Et Appliquee. 82: 1609-1621. PMID 21796223 DOI: 10.1351/Pac-Con-09-09-29 |
0.587 |
|
| 2010 |
Brooks TA, Kendrick S, Hurley L. Making sense of G-quadruplex and i-motif functions in oncogene promoters. The Febs Journal. 277: 3459-69. PMID 20670278 DOI: 10.1111/J.1742-4658.2010.07759.X |
0.559 |
|
| 2010 |
Kendrick S, Hurley L. Abstract LB-46: Chemo-sensitization by modulation of Bcl-2 expression: The first example of an i-motif interactive small molecule that modulates gene expression Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-46 |
0.617 |
|
| 2009 |
Kendrick S, Akiyama Y, Hecht SM, Hurley LH. The i-motif in the bcl-2 P1 promoter forms an unexpectedly stable structure with a unique 8:5:7 loop folding pattern. Journal of the American Chemical Society. 131: 17667-76. PMID 19908860 DOI: 10.1021/Ja9076292 |
0.606 |
|
| Show low-probability matches. |